TrialBMC research notes2013

Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study.

Eugenia Espinel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.